Daymark Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.7M Buy
266,410
+54,630
+26% +$12.7M 1.65% 11
2026
Q1
$51.8M Sell
211,780
-321
-0.2% -$74.8K 1.63% 11
2025
Q4
$43.9M Sell
212,101
-618
-0.3% -$122K 1.4% 12
2025
Q3
$39.4M Buy
212,719
+13,662
+7% +$2.34M 1.34% 12
2025
Q2
$30.4M Buy
199,057
+1,626
+0.8% +$250K 1.16% 15
2025
Q1
$32.7M Sell
197,431
-112,601
-36% -$17.6M 1.41% 11
2024
Q4
$27.7M Buy
310,032
+9,279
+3% +$1.44M 1.17% 12
2024
Q3
$29.6M Sell
300,753
-3,451
-1% -$550K 1.25% 11
2024
Q2
$27.2M Buy
304,204
+6,033
+2% +$897K 1.25% 12
2024
Q1
$28.5M Buy
298,171
+3,150
+1% +$501K 1.53% 11
2023
Q4
$27.7M Buy
295,021
+5,100
+2% +$782K 1.7% 11
2023
Q3
$26.7M Buy
289,921
+135,230
+87% +$22.3M 1.84% 9
2023
Q2
$25.6M Buy
154,691
+53,851
+53% +$8.69M 1.9% 8
2023
Q1
$15.6M Buy
100,840
+55,314
+121% +$8.93M 2.07% 9
2022
Q4
$8.04M Buy
+45,526
New +$7.86M 1.42% 18

Other funds holding JNJ

Daymark Wealth Partners's JNJ Position: Q2 2026 in Review

Daymark Wealth Partners increased its Johnson & Johnson (JNJ) stake by 26% in Q2 2026, buying an estimated $12.7M and bringing the position to 266,410 shares worth $67.7M. The position accounts for 1.65% of the portfolio, ranked #11.

Daymark Wealth Partners first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Daymark Wealth Partners held 266,410 shares of Johnson & Johnson worth $67.7M as of Q2 2026.
  • Daymark Wealth Partners bought 54,630 Johnson & Johnson shares in Q2 2026, an estimated $12.7M.
  • Johnson & Johnson made up 1.65% of Daymark Wealth Partners's portfolio in Q2 2026, its #11 holding.
  • Daymark Wealth Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.